TCTR20131204001
Recruiting
Phase 1
Comparative pharmacodynamics and pharmacokinetics study of generic and reference clopidogrel products in Thai Healthy volunteers
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Antiplatelet Agents
- Sponsor
- Khon Kaen University
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Age between 18 and 45 years
- •\- Body mass index between 18\-25 kg/m2
- •\- No clinically significant abnormalities, as confirmed on medical history; detailed physical examination; clinical laboratory analysis (blood hematology, biochemistry, prothrombin time, bleeding time, and urinalysis)
Exclusion Criteria
- •\- An allergy to any drug; and/or a history of drug and/or alcohol abuse.
- •\- Subjects who had donated blood within 3 months prior to the start of this study or had participated in another investigational drug study within 3 months prior to the start of this study
- •\- Participating subjects were instructed to abstain from the use of any drugs for at least 2 weeks before and throughout the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
FarmaPEG-Ione. Healthy volunteers.Healthy VolunteersRPCEC00000039Center for Genetic Engineering and Biotechnology (CIGB)16
Completed
Not Applicable
Comparative pharmacokinetics, pharmacodynamics, efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukaemia (ALL)ISRCTN75734403Medac GmbH (Germany)32
Completed
Not Applicable
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Low Body Weight versus Higher Body Weight Aspirin-Treated Subjects with Stable Coronary Artery DiseaseCoronary Artery Diseaseillness of coronary arteries10011082NL-OMON34026Eli Lilly25
Active, not recruiting
Not Applicable
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis - TABREUCTR2005-005292-15-SEEli Lilly and Company Ltd.110
Completed
Not Applicable
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Very Elderly versus Non-Elderly Aspirin-Treated Subjects with Stable Coronary Artery DiseaseCoronary Artery Diseaseillness of coronary arteries10011082NL-OMON34156Eli Lilly20